Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lisa Poulton

Trial Manager - Oncology Clinical Trials Office (OCTO)

I joined the Oncology Clinical Trials Office (OCTO) as a Trial Manager in June 2021 having previously worked in surgical trials for nearly 4 years. Prior to this I worked as a Trial Administrator in OCTO, and a Data Clerk at Warwick CTU. 

I am currently working on the following trials:

TebeMRD - A Phase II Non-Randomized, Open-label, Multi-centre Study of the Safety and Efficacy of Tebentafusp in Melanoma with Molecular Relapsed Disease

OCTOVA - Randomised Phase II Trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum–resistant ovarian cancer